Predictors of medication adherence in an AIDS clinical trial: Patient and clinician perceptions

Health and Social Work

Volumn 34, Issue 4, 2009, Pages 257-264

  Cox, Lisa E ^a  

^a RICHARD STOCKTON COLLEGE OF NEW JERSEY   (United States)

Author keywords

Adherence; Clinical trials; Compliance; Health belief model; HIV AIDS

Indexed keywords

ANTIINFECTIVE AGENT; COTRIMOXAZOLE;

ADULT; AIDS RELATED COMPLEX; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHNOLOGY; HUMAN; INFORMATION PROCESSING; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATIENT COMPLIANCE; PNEUMOCYSTIS PNEUMONIA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICAL MODEL; STATISTICS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; CD4 LYMPHOCYTE COUNT; DATA COLLECTION; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PATIENT COMPLIANCE; PNEUMONIA, PNEUMOCYSTIS; PROSPECTIVE STUDIES; RISK FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 73349102530     PISSN: 03607283     EISSN: 15456854     Source Type: Journal    
DOI: 10.1093/hsw/34.4.257     Document Type: Article

References (20)

1. Becker, M. H., & Maiman, L. A. (1975). Sociobehavioral determinants of compliance with health and medical care recommendations. Medical Care, 13, 10-24.
2. Besch, C. L. (1995). Compliance in clinical trials.Journal of Acquired Immune Deficiency Syndrome, 9, 1-10.
3. Blackwell, B. (1973). Drug therapy: Patient compliance. New England Journal of Medicine, 289, 249-252.
4. Boudes, P. (1998). Drug compliance in therapeutic trials: A review. Controlled Clinical Trials, 19, 257-268.
5. Cox, L. (2002). Social support, medication compliance and HIV/AIDS. Social Work in Health Care, 35, 425-460.
6. Diggle, P., Liang, K., & Zegers, P. (1994). Analysis of longitudinal data. Oxford, England: Clarendon Press.
7. Eldred, L.,Wu, A.W., Chiasson, R. E., & Moore, D. (1998). Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 18, 117-125.
8. El-Sadr,W. M., Luskin-Hawk, R.,Yurik,T. M.,Walker, J., Abrams, D.,John, S. L., et al. (1999).A randomized trial of daily and thrice-weekly trimethoprimsulfamethoxazole for the prevention of Pneumocystis carinii pneuomonia in human immunodeficiency virus-infected persons. Clinical Infectious Diseases, 29, 775-783.
9. Freedman, L. S. (1990). The effect of partial noncompliance on the power of a clinical trial. Controlled Clinical Trials, 11, 157-168.
10. Griffith, S. (1990). A review of the factors associated with patient compliance and the taking of prescribed medications. British Journal of General Practice, 40, 114-116.
11. Haynes, R. B. (1976).A critical review of the "determinants" of patient compliance with therapeutic regimens. In D. L. Sackett & R. B. Haynes (Eds.), Compliance with therapeutic regimens (pp. 26-39). Baltimore: Johns Hopkins University Press.
12. Horowitz, R. I., & Horowitz, S. M. (1993). Adherence to treatment and health outcomes. Archives of Internal Medicine, 153, 1863-1868.
13. Ickovis, J. R., & Weisler, A. W. (1997). Adherence in AIDS clinical trials: A framework for clinical research and clinical care. Journal of Clinical Epidemiology, 50, 385-391.
14. Kravitz, R. L., Hays, R. D., Sherbourne, C. D., DiMatteo, M. R., Rogers,W. H., Ordway, L., & Greenfield, S. (1993). Recall of recommendations and adherence to advice among patients with chronic medical conditions. Archives of Internal Medicine, 153, 1869-1878.
15. Morse, E.V., Simon, P. M., Coburn, M., Hyslop, N., Greenspan, D., & Balson, P. M. (1991). Determinants of subject compliance within an experimental anti-HIV drug protocol. Social Science and Medicine, 32, 1161-1167.
16. O'Brien, M. K., Petrie, R., & Raeburn,J. (1992).Adherence to medication regimens: Updating a complex medical issue. Medical Care Review, 49, 435-454.
17. Pekovic.V, Mayanja, H.,Vjecha, M.,Johnson,J., Okwera, A., Nsubuga, P., et al. (1998). Comparison of three composite compliance indices in a trial of self-administered preventive therapy for tuberculosis in HIV-infected Ugandan adults. Journal of Clinical Epidemiology, 51, 597-607.
18. Sackett, D. L., & Snow, J. C. (1979).The magnitude of compliance and non-compliance. In R. B. Haynes, D.Taylor, & D. L. Sackett (Eds.), Compliance in health care (pp. 11-22). Baltimore: Johns Hopkins University Press.
19. Williams.J. (1999).The role of social work in HIV/AIDS clinical trials. Social Work in Health Care, 29, 35-56.
20. Zachariah, R., Harries.A.D.,Arendt,V.,Wenning, R, Schneider, S., Spielmann, M., et al. (2001). Compliance with cotrimoxazole prophylaxis for the prevention of opportunistic infections in HIV-positive tuberculosis patients in Thyolo district, Malawi. International Journal of Tuberculosis Lung Disorders, 5, 843-846.